CoChat

A novel glutaminase inhibitor-968 inhibits the migration and proliferation of non-small cell lung cancer cells by targeting EGFR/ERK signaling pathway

Open access
Han, Tianyu, Guo, Meng, Zhang, Tingting, Gan, Mingxi, Xie, Caifeng, Wang, Jian-Bin · 2017 · Oncotarget
Cited by 55

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

// Tianyu Han 1, 2, * , Meng Guo 1, * , Tingting Zhang 3 , Mingxi Gan 1 , Caifeng Xie 1 , Jian-Bin Wang 1 1 Institute of Translational Medicine, Nanchang University, Nanchang City, Jiangxi 330031, China 2 School of Life Sciences, Nanchang University, Nanchang City, Jiangxi 330031, China 3 Research Institute of Applied Biology, Shanxi University, Taiyuan, Shanxi 030006, China * These authors have contributed equally to this work Correspondence to: Jian-Bin Wang, email: jianbinwang1@gmail.com Keywords: glutamine metabolism, glutaminase inhibitor, epidermal growth factor receptor, autophagy, non-small cell lung cancer Received: August 04, 2016 Accepted: November 15, 2016 Published: December 26, 2016 ABSTRACT Metabolic reprogramming is critical for cancer cell proliferation. Glutaminolysis which provides cancer cells with bioenergetics and intermediates for macromolecular synthesis have been intensively studied in recent years. Glutaminase C (GAC) is the first and rate-limiting enzyme in glutaminolysis and plays important roles in cancer initiation and progression. We previously screened a small molecule named 968, a specific inhibitor of GAC, to block the proliferation of human breast cancer cells. In this study, we found that 968 effectively inhibited NSCLC cell proliferation and migration and arrested G0/G1 phase of cell cycle. Furthermore, we demonstrated that 968 inhibited the EGFR/ERK pathway via decreasing the expression of EGFR and phospho-ERK. Apart from this, we discovered that 968 treatment induced autophagy to protect cells against apoptosis and the combination of 968 with autophagy inhibitor Chloroquine (CQ) had synergistic effects on the growth of NSCLC cells. Thus, our study pointed out a new therapeutic strategy for NSCLC treatment by combination of 968 with CQ.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.14188

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

Metadata

Authors
Han, T., Guo, M., Zhang, T., Gan, M., Xie, C., & Wang, J.-B.
Venue
Oncotarget
Published
2016-12-26
Volume
8
Issue
17
Pages
28063-28073
ISSN
1949-2553 (ISSN-L)
OpenAlex
W2560920946
Cited by
55
References
7
FWCI
1.70
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.